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Accepted 5 December 2012AbstractObjective: The goal of this study is to assess the feasibility of simple extrafascial hysterectomy for patients with clinical stage IA1 cervical
squamous cell carcinoma (SCC) after once conization regardless of any pathologic risk factor.
Materials and Methods: All cases with T1a1, SCC lesion in their cervical cone specimen were retrospectively collected after chart and pathology
review for the period between January 2002 and December 2009. All cases underwent subsequent hysterectomies within a month of diagnosis.
Pathologic risk factors of conization, surgical scale of hysterectomy, residual lesion of the uterus, necessity of adjuvant radiation therapy,
complications, and survival were analyzed in this study.
Results: Eighty-one cases were identified from the registry. Most were managed by simple hysterectomy (SH; 60/81, 74%), and the remaining 21
cases underwent modified radical hysterectomy (MRH). All cases without any risk factors in their cone specimens demonstrated residual lesion
T1a1 in both SH and MRH groups, whereas those with existing risk factor were confirmed positive for residual lesions T1a1 [SH, 95.8% (46/
48) vs. MRH, 75% (15/20)]. Only two cases in the SH group received adjuvant radiation for residual lesions >T1a1. On the contrary, 15 cases in
the MRH group can receive smaller scale surgery than MRH. All cases were recurrence-free without any permanent treatment-related
complication by the end of the study.
Conclusion: Extrafascial simple hysterectomy may be recommended for clinical T1a1 cervical SCC regardless of the pathologic risk factor.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Cervical cancer is the most common female genital tract
neoplasm worldwide. The persistent and long-term infection by
high-risk human papillomavirus are known to put women at high
risk of developing cervical intraepithelial neoplasms (CIN),which
may progress slowly to cervical cancer without medical* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei 104,
Taiwan.
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is surgical conization. The surgical conization procedure of the
uterine cervix plays important roles in the pathologic diagnosis
and treatment for high-grade CIN. Occasionally, T1a1 squamous
cell carcinoma (SCC) lesion (stromal invasion 3 mm, lateral
extent 7 mm) is found incidentally in the cervical cone spec-
imen. When this situation is encountered, simple hysterectomy
(SH) or modified radical hysterectomy (MRH) is often performed
if fertility is no longer a consideration [1,2]. Although comparable
cure rates have been reported for both SH andMRH, SH is known
to have better postoperative voiding and defecating function,
shorter operative and recovery time, and less intraoperativecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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ommended in the presence of risk factors, including lymphatic
vascular space invasion (LVSIþ) by dysplastic cells, invasion of
surgical margins in conization specimen, and/or presence of
dysplastic cells in the endocervical curettage (ECCþ) [3,4]. Some
physicians prefer MRH over SH in cases where re-conization of
the cervix is not an option because of the lack of confidence in the
surgical scale of SH. Postoperative adjuvant radiotherapy of the
pelvic is sometimes required if an upstage lesion is discovered in
the SH specimen. The choice of hysterectomy therefore relies
largely on patients’ clinical assessments as well as physician
preferences. There is an ongoing incentive to reduce the surgical
scale of hysterectomy in the management of early stage cervical
cancer, which renders less surgical complications and probably
equally favorable outcomes.
At present, the surgical scale of stage IA1 cervical SCC has
been shrunk gradually without survival difference [3]. Because
conization is also acceptable in the early-stage disease to
preserve fertility [5e7], the replacement of MRH by SH is a
definite possibility if both procedures render similar survi-
vorship. Nonetheless, there is still insufficient evidence
showing that SH can always be an alternative procedure in
cone biopsy proof clinical stage IA1 cervical cancer with any
pathologic risk factor. The present study raises the hypothesis
that SH is a sufficient surgical intervention to replace MRH in
the cases with T1a1 SCC lesion after only once conization
even in the presence of pathologic risk factor(s).
Materials and methods
A retrospective chart and pathology review was conducted
after approval by the institutional review boards and ethicalFig. 1. The study algorithm (T1a1: stromal invasion 3 mm, lateral extent 7 m
including LVSIþ, ECCþ, and/or the surgical margin involvement in the cone spe
concurrent chemoradiation therapy; SCC ¼ squamous cell carcinoma; SH ¼ simpcommittees at Mackay Memorial Hospital in Taipei, Taiwan.
All cases with the T1a1 (stromal invasion 3 mm, lateral
extent 7 mm), SCC lesion in their cervical cone specimen
were retrospectively collected from the hospital’s pathologic
database for the period between January 2002 and December
2009. Histology, other than SCC, was excluded from the study
because the definition of microinvasive adenocarcinoma or
adenosquamous carcinoma was still controversial in pathol-
ogy. All cases underwent subsequent hysterectomies, either
SH or MRH, within a month after a confirmed diagnosis of
cervical cancer. Cone specimens were categorized into two
groups according to the presence or absence of pathologic risk
factor(s). The definition of pathologic risk factors includes
LVSIþ, and/or surgical margin invasion, and/or a presence of
dysplastic cells in ECC [4]. The cases were further categorized
into two study groups based on their surgical scale (SH or
MRH).
Surgical specimens following hysterectomies were catego-
rized into either those with residual tumor T1a1 SCC (no re-
sidual lesion, residual CIN only, or residual T1a1 SCC only); or
those with residual tumor T1a2 SCC (depth of invasion
>3 mm or lateral extent >7 mm, upstaged condition). The al-
gorithm of this study is demonstrated in detail in Fig. 1. Other
pathologic parameters in MRH group, including parametrial
condition and status of pelvic lymph nodes, were also extracted
from the medical charts.
All cases were followed-up until June 2012, the date of last
follow-up or death from the date of initial treatment. Treat-
ment outcomes, recurrent status, complications of surgery, and
adjuvant radiation therapy were also recorded.
Statistical association of pathologic risk factors of cone
specimens between SH and MRH group was assessed bym, T1a2: stromal invasion >3 mm, lateral extent >7 mm). aRisk factor(s),
cimen. MRH ¼ modified radical hysterectomy; RT/CCRT: radiation therapy/
le hysterectomy.
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pected count 5) and Student t test for categorical and contin-
uous variables, respectively with SPSS for Windows release
R18 (SPSS Inc, Chicago, IL, USA). A p value < 0.05 was
considered statistically significant.
Results
Eighty-one cases were included after chart and pathology
review, including 60 SH cases and 21 MRH cases. Seventeen
cases with combination pathology more than SCC were
excluded due to their pathologic heterogeneity. The clinical
characteristics and related statistics in the cone specimens are
organized according to risk factors as shown in Table 1. There
were no statistical difference between SH and MRH groups. In
the final pathology of the specimens of all hysterectomies, 23
cases (28.4%) had residual T1a1 lesion, 17 cases (21.0%) had
residual CIN only, and 34 cases (42.0%) did not have any re-
sidual disease. Only seven cases had the residual diseaseT1a2.
The majority of the cases who received only SH after con-
ization (60/81, 74%) were adult females with a median age of
45 years at initial diagnosis. Most (48/60, 80%) were confirmed
positive for at least one risk factor. Residual tumorT1a1 SCC
was found in almost all cases with the confirmed risk factor (46/
48, 95.8%). Residual tumorT1a2 was found in only two cases
(2/48, 4.2%). In other words, management by SH is adequate for
almost all cases with confirmed risk factor(s), except in two
cases, which required postoperative adjuvant radiation therapy
because of the inadequate scale of hysterectomy. Additionally,
all 12 cases without any pathologic risk factors in their cone
specimens had residual lesion T1a1 SCC (100%).
The remaining cases that received MRH after conization
(21/81, 26%) were slightly older with a median age of 52 years
at initial diagnosis. Most (20/21, 95%) were confirmed posi-
tive for at least one risk factor in the cone specimens. Residual
tumor T1a1 SCC was found in three-fourths of the cases
Table 1
The basic characteristics and distribution of pathologic risk factors in the cone
specimen.
Characters Condition SH
(n ¼ 60)
MRH
(n ¼ 21)
pa
Median age (y) 45 52 0.111
(1) LVSI Positive 3 (5) 4 (19) 0.058
Negative 51 (85) 17 (81)
Unknown 6 (10) 0
(2) Exocervical
margin invasion
Positive 21 (35) 9 (42.9) 0.168
Negative 30 (50) 12 (57.1)
Cannot be evaluated 9 (15) 0
(3) Endocervical
margin invasion
Positive 36 (60) 17 (81) 0.109
Negative 15 (25) 4 (19)
Cannot be evaluated 9 (15) 0
(4) ECC Presence of dysplastic
cells
30 (50) 11 (52.4) 0.927
Absence of dysplastic
cells
28 (46.7) 9 (42.9)
Cannot be evaluated 2 (3.3) 1 (4.8)
ECC ¼ endocervical curettage; LVSI ¼ Lymphatic vascular space invasion;
MRH ¼ modified radical hysterectomy; SH ¼ simple hysterectomy.
a Student t test for age and Chi-square test for (1)e(4).(15/20, 75%), and management by MRH appeared to be “too
much” for them. Only the remaining five cases (25%) with
residual SCC T1a2 seemed to benefit from the surgical scale
of MRH. No residual SCC was found in the cone specimen of
one MRH case without any risk factor. No one in the MRH
group had parametrial tumor spread and/or pelvic lymph
nodes metastasis after pathologic inspection.
In the outcome of these cases of both the SH and MRH
groups, all cases (100%) were alive and recurrence-free by the
end of the study. All of them were absence of permanent
treatment-related complications according to the chart record.
Discussion
Early cervical cancer can sometimes be discovered acci-
dentally during the conization procedure for the treatment of
high-grade CIN. When this situation is encountered, hyster-
ectomy is often strongly recommended for older women who
are either postmenopausal or those who have already given
birth to children. Pathologic findings of cone specimen are
important for clinicians while deciding the surgical scale of
hysterectomy. Factors of consideration include surgical margin
involvement, the existence of dysplastic cells in ECC spec-
imen, and the presence of LVSI [4,8].
Re-conization prior to hysterectomy after the first coniza-
tion has been suggested for the assessment of disease exten-
sion and invasion prior to hysterectomy. However, repeat
conization is sometimes extremely difficulty if the residual
cervical tissue is not enough or senile retracted cervix is
encountered. The following hysterectomy would be postponed
if repeated conization is necessary. In our original database, 12
cases received re-conization and showed the “upstaged” con-
dition (7 cases changed the stage to IA2, 5 cases changed to
IB1). However, these cases were not enrolled into our study
because they did not fit our selection criteria.
According to the recent cervical cancer management
guidelines from the National Comprehensive Cancer Network
(NCCN) [1], the scale of surgery (SH or MRH) of stage IA1
Cx Ca is based solely on the LVSI status in cone specimen.
However, some gynecologic oncologists have suggested pelvic
lymph nodes dissection with MRH in the presence of LVSIþ
[1]. Whether or not MRH is always necessary in such early
stage cervical cancer cases with only LVSIþ is debatable. The
beneficial and morbidity from MRH needs to be re-evaluated
on the basis of the current clinical data.
A Korean series mentioned that 83.3% of cases can choose
SH safely even with the presence of invasive carcinoma at
cone margins [9]. In our series, cases with SCC received only
once conization with any pathologic risk factor demonstrated
over 95% adequate rate in the SH group. In fact, nearly 80% of
SCC cases in the MRH group seemed to be “overscaled” and
their MRH can be safely replaced with SH. Parametrial in-
vasion and lymph nodes metastases were not seen in the pa-
thology review of MRH group. However, still near 5%
unfortunate cases in SH group needed the adjuvant radio-
therapy because of “upstage” in the specimen of hysterectomy
after surgery.
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MRH involves longer operative time, more blood loss, and
longer hospital stay, as well as more urologic complications,
such as urogenital fistula and bladder dysfunction [10]. Con-
stipation can often be observed clinically after MRH. The
morbidity and mortality of MRH reported by Magrina et al [11]
concluded that MRH has more complications (about 10%) after
surgery than SH, including urinary tract infection, inability to
void, and fistula.
Smaller-scale surgery does not represent the compromise of
the treatment [3,5,12]. Decreasing the surgical destruction in
treating cervical cancer cases is the recent trend in the world
[5,12]. In our series, either SH or MRH group, treatment
outcome is excellent without disease recurrence and perma-
nent treatment-related complications. In fact, the only two
cases that needed radiation therapy after surgery developed
ovarian failure and only some acute toxicities of radiation
therapy. Fortunately, no long-term sequelae related to radiation
therapy was observed. Based on the final excellent survivor-
ship, replacing MRH with SH might be reasonable.
In conclusion, SH is a safe and adequate surgical scale for
treating clinical T1a1 SCC cervical cancer regardless of any
risk factor in the cone specimen. MRH could be replaced by
SH in order to prevent possible co-morbidities while main-
taining the same survival benefits.
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